The underlying mechanisms of wound healing are complex but inflammation is one of the
determining factors. Besides its traditional role in combating against infection upon injury …

Abstract Botulinum Toxin Type A is a potent neurotoxin that is produced by a gram‐positive
bacteria clostridium botulinum. Its utilization in the treatment of various medical condition …

Background The optimal treatment for hypertrophic scar and keloid remains controversial.
Therefore, the aim of this systematic review and meta-analysis was to compare the …

Introduction: Administration of botulinum toxin is an increasingly popular procedure in the
medical and aesthetic field. There is emerging evidence that it can influence fibroblast …

Background Scars exposed on the body surface lead to a large psychological burden on
patients. However, no satisfactory scar treatments exist. Botulinum toxin type A is a …

Background Consequently, the management of post burn hypertrophic scars and keloid in
children are a great challenge for the physicians, parents, and children themselves. Purpose …

Hypertrophic scar is a dermal fibroproliferative disease characterized by the overproduction
and deposition of extracellular matrix, and the hyperproliferation and enhanced …

Background Botulinum toxin type A-induced “chemoimmobilization” has long been utilized
for improved scar quality and wound healing; however, current evidence is limited to small …

Thyroidectomy scars, located on the exposed site, can cause distress in patients. Owing to
the cosmetic importance of thyroidectomy scars, many studies have been conducted on its …

Background Active prevention and treatment of scars are particularly important. Several
studies have used botulinum toxin type A (BTXA) to prevent postoperative scarring. The aim …